DekaBank Deutsche Girozentrale
BOLD

DekaBank Deutsche Girozentrale’s Audentes Therapeutics, Inc BOLD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18,800
Closed -$700K – 1174
2019
Q2 		$700K Buy
18,800
+7,300
+63% +$280K ﹤0.01% 864
2019
Q1 		$418K Buy
11,500
+2,100
+22% +$60.2K ﹤0.01% 938
2018
Q4 		$197K Sell
9,400
-2,100
-18% -$54.2K ﹤0.01% 970
2018
Q3 		$418K Sell
11,500
-300
-3% -$11.2K ﹤0.01% 960
2018
Q2 		$436K Hold
11,800
– – ﹤0.01% 934
2018
Q1 		$344K Buy
+11,800
New +$399K ﹤0.01% 925

Other funds holding BOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BOLD Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Audentes Therapeutics, Inc (BOLD) in Q3 2019, closing a stake of 18,800 shares — an estimated $700K sold.

DekaBank Deutsche Girozentrale first reported a position in BOLD in Q1 2018 and held it in 6 quarters. The position peaked at $700K in Q2 2019. 149 funds tracked by Wall St. Rank hold BOLD as of Q3 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Audentes Therapeutics, Inc position as of Q3 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 18,800 Audentes Therapeutics, Inc shares in Q3 2019, an estimated $700K.
  • DekaBank Deutsche Girozentrale first reported a position in Audentes Therapeutics, Inc in Q1 2018 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's Audentes Therapeutics, Inc position peaked at $700K in Q2 2019.
  • 149 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.